DolaLock

1 stories · following the connections

Business

Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

By Nasdaq OMXApr 17, 2018, 5:01 PM UTC